CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial
2012 · British Journal of Cancer · 44 citations
https://doi.org/10.1038/bjc.2011.593
J
J. Alexandre
Hôpital Cochin(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
1.2K
Citations
20
h-index
26
i10-index
J. Alexandre is an academic researcher from Hôpital Cochin. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Ovarian cancer diagnosis and treatment & Prostate Cancer Treatment and Research. The author has an h-index of 20, co-authored 74 publications.
Papers by this author
worksA single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery
2021 · ESMO Open · 26 citations
https://doi.org/10.1016/j.esmoop.2021.100209
Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis
2016 · Breast Cancer Research and Treatment · 13 citations
https://doi.org/10.1007/s10549-016-3798-8
712MO Final overall survival (OS) from the phase III ATALANTE/ENGOT-ov29 trial evaluating atezolizumab (Atz) versus placebo with standard chemotherapy (Cx) plus bevacizumab (bev) in ovarian cancer (OC) patients (pts) with platinum-sensitive relapse (PSR)
2024 · Annals of Oncology · 3 citations
https://doi.org/10.1016/j.annonc.2024.08.774
2484P Prognostic value of SLCO2B1 and HSD3B1 polymorphisms in patients with metastatic castration resistant prostate cancer treated with abiraterone: an ancillary analysis of OPTIMABI phase II trial
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.3099
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat